Related Experiment Video
Updated: May 23, 2026

06:46
Using Herbal-Cake-Separated Moxibustion for the Treatment of Rats with Chronic Renal Failure
Published on: December 22, 2023
Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease
Josne C Paterno1, Cássia T Bergamaschi, Ruy R Campos
1Nephrology Division, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Kidney & Blood Pressure Research
|April 5, 2012
Summary
Electroacupuncture (EA) and moxibustion (MO) significantly improved kidney function in a rat model of chronic kidney disease (CKD). This treatment likely works by regulating sympathetic nerve activity and nitric oxide levels.
Area of Science:
- Nephrology
- Traditional Chinese Medicine
- Cardiovascular Physiology
Background:
- Chronic kidney disease (CKD) is a growing global health concern.
- The sympathetic nervous system and nitric oxide are implicated in CKD development.
- Traditional Chinese Medicine offers therapeutic strategies like Electroacupuncture (EA) and Moxibustion (MO).
Purpose of the Study:
- To evaluate the renal and hemodynamic effects of EA-MO in a rat model of CKD.
- To investigate the impact of EA-MO on sympathetic nerve activity and nitric oxide levels.
- To assess the therapeutic potential of EA-MO for managing CKD.
Main Methods:
- Male Wistar rats underwent 5/6th nephrectomy (NX) and were divided into four groups: control, NX only, NX with sham EA-MO, and NX with real EA-MO.
- Studies included biochemical analysis, blood pressure monitoring, renal sympathetic nerve activity measurement, nitric oxide level assessment, and histopathological evaluation.
- The study duration was 8 weeks.
Main Results:
- The group treated with EA-MO demonstrated significant improvements in all assessed functional parameters.
- Histopathological indices also showed significant improvement in the EA-MO treated group.
- These results indicate a positive impact of EA-MO on kidney health.
Conclusions:
- EA-MO exhibits beneficial effects in managing experimental chronic kidney disease.
- The therapeutic benefits are likely mediated through modulation of renal sympathetic nerve activity and nitric oxide levels.
- This modulation leads to reduced blood pressure and decreased proteinuria, suggesting a protective role in CKD.
